UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

Frontiers in oncology, 2018-07, Vol.8, p.262-262

2018

Volltextzugriff (PDF)

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Journal of clinical oncology, 2021-04, Vol.39 (12), p.1329-1338

2021

Volltextzugriff (PDF)

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2940-2950

2014

Volltextzugriff (PDF)

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

Clinical cancer research, 2019-10, Vol.25 (19), p.5832-5842

2019

Volltextzugriff (PDF)

Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patients

Cancer treatment reviews, 2018-02, Vol.63, p.116-121

2018

Volltextzugriff (PDF)

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

The New England journal of medicine, 2022-05, Vol.386 (21), p.1973-1985

2022

Volltextzugriff (PDF)

Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3684-3690

2009

Volltextzugriff (PDF)

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

The lancet oncology, 2018-03, Vol.19 (3), p.295-309

2018

Volltextzugriff (PDF)

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

The lancet oncology, 2019-09, Vol.20 (9), p.1273-1285

2019

Volltextzugriff (PDF)

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

Journal of clinical oncology, 2017-12, Vol.35 (36), p.4057-4065

2017

Volltextzugriff (PDF)

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Clinical cancer research, 2020-10, Vol.26 (19), p.5140-5152

2020

Volltextzugriff (PDF)

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)

Cancer, 2016-11, Vol.122 (22), p.3464-3471

2016

Volltextzugriff (PDF)

Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (14), p.3769-3782

2018

Volltextzugriff (PDF)

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

The New England journal of medicine, 2023-04, Vol.388 (17), p.1547-1558

2023

Volltextzugriff (PDF)

Bloodless surgery in urologic oncology: A review of hematologic, anesthetic, and surgical considerations

Urologic oncology, 2023-04, Vol.41 (4), p.192-203

2023

Volltextzugriff (PDF)

Pak2 Regulates Hematopoietic Progenitor Cell Proliferation, Survival, and Differentiation

Stem cells (Dayton, Ohio), 2015-05, Vol.33 (5), p.1630-1641

2015

Volltextzugriff (PDF)

Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study

Clinical cancer research, 2020-03, Vol.26 (5), p.1000-1008

2020

Volltextzugriff (PDF)

Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease

Journal of clinical oncology, 2022-12, Vol.40 (34), p.3940-3951

2022

Volltextzugriff (PDF)

Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2016-02, Vol.92, p.29-34

2016

Volltextzugriff (PDF)

Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma

Leukemia & lymphoma, 2024, Vol.65 (1), p.14-25

2024

Volltextzugriff (PDF)

Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study

Annals of surgical oncology, 2022-09, Vol.29 (9), p.5937-5945

2022

Volltextzugriff (PDF)

An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

Journal of clinical epidemiology, 2018-07, Vol.99, p.75-83

2018

Volltextzugriff (PDF)

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Journal of clinical oncology, 2022-08, Vol.40 (22), p.2468-2478

2022

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionProject MUSE All Journals

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Humans
(31)
Middle Aged
(18)
Female
(16)
Male
(16)
Aged
(15)
Adult
(11)
Neoplasm Staging
(11)
Patients
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Prognosis
(9)
Follow-Up Studies
(8)
Treatment Outcome
(8)
Clinical Trials
(7)
Metastasis
(7)
Retrospective Studies
(7)
Surgery
(7)
Cancer Therapies
(6)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials

Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patients

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)

Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Bloodless surgery in urologic oncology: A review of hematologic, anesthetic, and surgical considerations

Pak2 Regulates Hematopoietic Progenitor Cell Proliferation, Survival, and Differentiation

Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study

Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease

Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer

Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma

Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study

An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Aktive Filter

Suchergebnisse filtern